How should bacterial gastroenteritis be treated in children, including indications for antibiotic therapy and recommended regimens for specific bacterial pathogens?

Treatment of Bacterial Gastroenteritis in Children

Most children with bacterial gastroenteritis should receive supportive care with oral rehydration therapy alone, without antibiotics, as empiric antimicrobial therapy is not recommended for immunocompetent children except in specific high-risk situations. 1

Supportive Care: The Foundation of Treatment

Rehydration Strategy

• Reduced osmolarity oral rehydration solution (ORS) is first-line therapy for mild to moderate dehydration and should be started immediately 1
• Intravenous fluids (lactated Ringer's or normal saline) are reserved for severe dehydration, shock, altered mental status, or ORS failure 1
• Continue breastfeeding throughout the illness and resume age-appropriate diet immediately after rehydration 1

Adjunctive Therapies

• Antimotility drugs (loperamide) are contraindicated in all children <18 years with acute diarrhea 1
• Ondansetron may be given to children >4 years to facilitate oral rehydration tolerance 1
• Probiotics (Lactobacillus GG or Saccharomyces boulardii) may reduce symptom duration 1, 2
• Zinc supplementation for children 6 months-5 years in areas with high zinc deficiency prevalence 1

Indications for Antibiotic Therapy

When to Treat: Specific Clinical Scenarios

Empiric antibiotics are indicated ONLY in these situations: 1

1. Infants <3 months of age with suspected bacterial etiology
2. Bacillary dysentery (frequent scant bloody stools, fever, abdominal cramps, tenesmus) presumptively due to Shigella
3. International travelers with temperature ≥38.5°C and/or signs of sepsis
4. Immunocompromised children with severe illness and bloody diarrhea
5. Suspected enteric fever with sepsis features (requires blood, stool, and urine cultures first)

When NOT to Treat

Antibiotics should be avoided in: 1

• Most immunocompetent children with bloody or watery diarrhea
• STEC O157 and other STEC producing Shiga toxin 2 (strong contraindication due to HUS risk)
• Persistent watery diarrhea lasting ≥14 days
• Asymptomatic contacts of infected individuals

Antibiotic Regimens by Pathogen

Empiric Therapy (When Indicated)

For children: 1

• Infants <3 months or neurologic involvement: Third-generation cephalosporin (ceftriaxone)
• Older children: Azithromycin (preferred based on local susceptibility and travel history)

Targeted Therapy by Specific Pathogen

Shigella: 3, 4

• First-line: Azithromycin (preferred due to rising resistance)
• Treatment is indicated for all confirmed cases given high transmissibility

Campylobacter: 3, 4

• Azithromycin is preferred
• Treatment only indicated for severe cases, particularly in early phase of illness
• Most cases resolve without antibiotics

Non-Typhi Salmonella: 3, 4, 5

• Ceftriaxone or ciprofloxacin when treatment is necessary
• Treatment restricted to:
  • Infants <3-6 months
  • Immunocompromised patients
  • Patients with underlying conditions (sickle cell disease, immunosuppression)
  • Signs of systemic infection or bacteremia
  • Prolonged diarrhea
• Most cases should NOT be treated as antibiotics may prolong carrier state

Typhi/Paratyphi (Enteric Fever): 1

• Broad-spectrum therapy initially, then narrow based on susceptibilities
• Obtain blood, stool, and urine cultures before starting treatment
• Tailor to local resistance patterns from acquisition location

STEC (Shiga toxin-producing E. coli): 1

• Antibiotics are CONTRAINDICATED for STEC O157 and Shiga toxin 2-producing strains (increases HUS risk)
• Non-O157 STEC without Shiga toxin 2: insufficient evidence, generally avoid

Critical Pitfalls to Avoid

1. Never give antibiotics empirically for bloody diarrhea in immunocompetent children without meeting specific criteria—this includes avoiding treatment while awaiting stool culture results 1

2. Never treat suspected or confirmed STEC infections with antibiotics due to increased hemolytic uremic syndrome risk 1

3. Avoid treating non-Typhi Salmonella in most children as this prolongs carrier state without clinical benefit 3, 4, 5

4. Do not use antimotility agents in any child <18 years with acute diarrhea 1

5. Empirical treatment without bacterial identification is not indicated except for severe sepsis or high-risk patients (sickle cell disease, immunocompromised) 3, 4, 6

Monitoring and Follow-up

• Reassess fluid/electrolyte balance and nutritional status in children with persistent symptoms 1
• Consider non-infectious causes (lactose intolerance, IBD, IBS) if symptoms persist ≥14 days 1
• Follow-up stool testing is not needed for case management but may be required by public health authorities for return to childcare 1
• Modify or discontinue antibiotics when specific organism is identified 1